pediatric acute myeloid leukemia

KDM6A: An Emerging Biomarker for Prediction of Treatment Response and Relapse in Pediatric Acute Myeloid Leukemia
Comparison of HAG and DAE Induction Regimens in Pediatric Acute Myeloid Leukemia Patients
Gilteritinib in Children with Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation – Single-Center Experience
Molecular Genetic Diagnostics in the Era of Genomic Medicine: Which method to choose to describe molecular profile of acute myeloid leukemia in children